106 related articles for article (PubMed ID: 37017667)
1. Analysis of the Secreted Peptidome from Omental Adipose Tissue in High-Grade Serous Ovarian Cancer.
Pan H; Xu S; Dai C; Jia G; Ge L; Xu P; Jia X
Crit Rev Eukaryot Gene Expr; 2023; 33(3):27-38. PubMed ID: 37017667
[TBL] [Abstract][Full Text] [Related]
2. Analysis of secreted peptidome from omental adipose tissue in polycystic ovarian syndrome patients.
Jia G; Tao H; Xue Y; Xu S; Xue K; Zhu Q; Chen X; Liu X; Xu S; Li Q; Xu P
J Cell Physiol; 2018 Aug; 233(8):5885-5894. PubMed ID: 29226956
[TBL] [Abstract][Full Text] [Related]
3. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
Li J; Liu D; Cui M; Wei Z
J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based peptidome profiling of human serous ovarian cancer tissues.
Xu J; Wang X; Xu P; Liu S; Teng F; Liu X; Zhu Q; Hua X; Gong Z; Jia X
Int J Biochem Cell Biol; 2019 Feb; 107():53-61. PubMed ID: 30543932
[TBL] [Abstract][Full Text] [Related]
5. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
6. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
Zhang P; He M; Zeng Y; Cai X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression Profiles and Function Prediction of Transfer RNA-Derived Fragments in High-Grade Serous Ovarian Cancer.
Chen B; Liu S; Wang H; Li G; Lu X; Xu H
Biomed Res Int; 2021; 2021():5594081. PubMed ID: 33860037
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer.
Gao Y; Zhang C; Liu Y; Wang M
Biosci Trends; 2019 May; 13(2):204-211. PubMed ID: 31019161
[TBL] [Abstract][Full Text] [Related]
9. Differential histone deacetylase inhibitor-induced perturbations of the global proteome landscape in the setting of high-grade serous ovarian cancer.
Duda JM; Twigg CAI; Thomas SN
Proteomics; 2023 Feb; 23(3-4):e2100372. PubMed ID: 36193784
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer.
Xiang L; Rong G; Zhao J; Wang Z; Shi F
Oncol Lett; 2018 May; 15(5):7769-7775. PubMed ID: 29731902
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Peptidomic Characterization of Cultured Skeletal Muscle Tissues Derived From
Wu Y; Han M; Wang Y; Gao Y; Cui X; Xu P; Ji C; Zhong T; You L; Zeng Y
Front Endocrinol (Lausanne); 2019; 10():741. PubMed ID: 31736878
[TBL] [Abstract][Full Text] [Related]
12. Omental Macrophagic "Crown-like Structures" Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer.
Liang YL; Lin CN; Tsai HF; Wu PY; Lin SH; Hong TM; Hsu KF
Curr Oncol; 2021 Oct; 28(5):4234-4246. PubMed ID: 34677277
[TBL] [Abstract][Full Text] [Related]
13. Tumor specific methylome in Chinese high-grade serous ovarian cancer characterized by gene expression profile and tumor genotype.
Song F; Li L; Zhang B; Zhao Y; Zheng H; Yang M; Li X; Tian J; Huang C; Liu L; Wang Q; Zhang W; Chen K
Gynecol Oncol; 2020 Jul; 158(1):178-187. PubMed ID: 32362568
[TBL] [Abstract][Full Text] [Related]
14. WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer.
Lee S; Jun J; Kim WJ; Tamayo P; Howell SB
Anticancer Res; 2020 Nov; 40(11):6017-6028. PubMed ID: 33109540
[TBL] [Abstract][Full Text] [Related]
15. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
16. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
Qi G; Ma H; Li Y; Peng J; Chen J; Kong B
Cell Death Dis; 2021 Dec; 12(12):1135. PubMed ID: 34876569
[TBL] [Abstract][Full Text] [Related]
17. Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry.
Huh S; Kang C; Park JE; Nam D; Kim SI; Seol A; Choi K; Hwang D; Yu MH; Chung HH; Lee SW; Kang UB
J Proteome Res; 2022 Sep; 21(9):2146-2159. PubMed ID: 35939567
[TBL] [Abstract][Full Text] [Related]
18. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
19. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer.
Si M; Zhang J; Cao J; Xie Z; Shu S; Zhu Y; Lang J
Onco Targets Ther; 2019; 12():10057-10075. PubMed ID: 31819501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
